Race/Ethnicity
Visit (Number) vs AM Pulse 2nd Measurement
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
| Clinical Evaluation (CE) | 1,504 | 65.7 | ± 21.3 | 70.0 | -2.0 | 120.0 | 12 | 1,516 |
| Diagnostic Visit (DX) | 1,232 | 66.9 | ± 12.9 | 67.0 | -3.0 | 104.0 | 284 | 1,516 |
| CPAP Titration Visit (CPAP) | 1,056 | 64.4 | ± 18.1 | 66.0 | -3.0 | 109.0 | 460 | 1,516 |
| Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 66.0 | ± 12.1 | 66.0 | -2.0 | 96.0 | 637 | 1,516 |
| Four Month Post-CPAP Neurocognitive Visit (4M) | 833 | 59.0 | ± 29.2 | 68.0 | -2.0 | 108.0 | 683 | 1,516 |
| Six Month Post-CPAP Neurocognitive Visit (6M) | 851 | 65.9 | ± 12.6 | 66.0 | -2.0 | 100.0 | 665 | 1,516 |
Gender vs AM Pulse 2nd Measurement
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs AM Pulse 2nd Measurement
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,504 | 65.7 | ± 21.3 | 70.0 | -2.0 | 120.0 | 12 | 1,516 |
| Male | 950 | 65.0 | ± 21.5 | 68.0 | -2.0 | 120.0 | 8 | 958 |
| Female | 554 | 66.7 | ± 21.0 | 72.0 | -2.0 | 114.0 | 4 | 558 |
Gender vs AM Pulse 2nd Measurement
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,232 | 66.9 | ± 12.9 | 67.0 | -3.0 | 104.0 | 284 | 1,516 |
| Male | 788 | 66.4 | ± 12.8 | 66.0 | -3.0 | 104.0 | 170 | 958 |
| Female | 444 | 67.8 | ± 12.8 | 68.0 | -1.0 | 96.0 | 114 | 558 |
Gender vs AM Pulse 2nd Measurement
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,056 | 64.4 | ± 18.1 | 66.0 | -3.0 | 109.0 | 460 | 1,516 |
| Male | 693 | 63.9 | ± 18.1 | 66.0 | -3.0 | 109.0 | 265 | 958 |
| Female | 363 | 65.3 | ± 18.1 | 68.0 | -3.0 | 102.0 | 195 | 558 |
Gender vs AM Pulse 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 879 | 66.0 | ± 12.1 | 66.0 | -2.0 | 96.0 | 637 | 1,516 |
| Male | 572 | 65.2 | ± 12.4 | 65.5 | -2.0 | 92.0 | 386 | 958 |
| Female | 307 | 67.4 | ± 11.6 | 68.0 | -1.0 | 96.0 | 251 | 558 |
Gender vs AM Pulse 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 833 | 59.0 | ± 29.2 | 68.0 | -2.0 | 108.0 | 683 | 1,516 |
| Male | 541 | 58.4 | ± 28.9 | 68.0 | -2.0 | 108.0 | 417 | 958 |
| Female | 292 | 60.1 | ± 29.8 | 70.0 | -2.0 | 104.0 | 266 | 558 |
Gender vs AM Pulse 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 851 | 65.9 | ± 12.6 | 66.0 | -2.0 | 100.0 | 665 | 1,516 |
| Male | 552 | 65.2 | ± 13.1 | 64.0 | -1.0 | 96.0 | 406 | 958 |
| Female | 299 | 67.3 | ± 11.6 | 66.0 | -2.0 | 100.0 | 259 | 558 |
Race/Ethnicity vs AM Pulse 2nd Measurement
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs AM Pulse 2nd Measurement
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,504 | 65.7 | ± 21.3 | 70.0 | -2.0 | 120.0 | 12 | 1,516 |
| Native American | 27 | 67.7 | ± 22.2 | 72.0 | -2.0 | 96.0 | 1 | 28 |
| Asian | 88 | 69.2 | ± 15.7 | 71.0 | -1.0 | 96.0 | 1 | 89 |
| Black | 170 | 63.4 | ± 25.0 | 71.5 | -1.0 | 102.0 | 2 | 172 |
| Hispanic | 114 | 67.3 | ± 18.8 | 70.0 | -1.0 | 96.0 | 2 | 116 |
| White | 1,096 | 65.5 | ± 21.2 | 70.0 | -2.0 | 120.0 | 6 | 1,102 |
| Other | 9 | 63.9 | ± 25.1 | 70.0 | -1.0 | 80.0 | - | 9 |
Race/Ethnicity vs AM Pulse 2nd Measurement
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,232 | 66.9 | ± 12.9 | 67.0 | -3.0 | 104.0 | 284 | 1,516 |
| Native American | 20 | 68.6 | ± 8.8 | 67.0 | 56.0 | 84.0 | 8 | 28 |
| Asian | 74 | 65.3 | ± 13.4 | 64.0 | -1.0 | 88.0 | 15 | 89 |
| Black | 120 | 67.6 | ± 12.3 | 68.0 | -1.0 | 90.0 | 52 | 172 |
| Hispanic | 84 | 68.9 | ± 9.9 | 68.0 | 48.0 | 95.0 | 32 | 116 |
| White | 926 | 66.9 | ± 12.8 | 67.5 | -3.0 | 104.0 | 176 | 1,102 |
| Other | 8 | 48.3 | ± 31.2 | 62.0 | -1.0 | 76.0 | 1 | 9 |
Race/Ethnicity vs AM Pulse 2nd Measurement
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,056 | 64.4 | ± 18.1 | 66.0 | -3.0 | 109.0 | 460 | 1,516 |
| Native American | 16 | 56.3 | ± 30.1 | 65.5 | -1.0 | 92.0 | 12 | 28 |
| Asian | 58 | 67.5 | ± 8.2 | 65.0 | 56.0 | 90.0 | 31 | 89 |
| Black | 96 | 64.3 | ± 21.7 | 68.0 | -1.0 | 102.0 | 76 | 172 |
| Hispanic | 73 | 67.8 | ± 15.5 | 68.0 | -1.0 | 96.0 | 43 | 116 |
| White | 808 | 64.1 | ± 17.9 | 66.0 | -3.0 | 109.0 | 294 | 1,102 |
| Other | 5 | 56.4 | ± 32.5 | 68.0 | -1.0 | 76.0 | 4 | 9 |
Race/Ethnicity vs AM Pulse 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 879 | 66.0 | ± 12.1 | 66.0 | -2.0 | 96.0 | 637 | 1,516 |
| Native American | 13 | 67.4 | ± 9.3 | 64.0 | 58.0 | 88.0 | 15 | 28 |
| Asian | 49 | 65.3 | ± 6.2 | 64.0 | 56.0 | 80.0 | 40 | 89 |
| Black | 77 | 64.8 | ± 17.8 | 68.0 | -1.0 | 96.0 | 95 | 172 |
| Hispanic | 65 | 67.7 | ± 12.7 | 66.0 | -1.0 | 92.0 | 51 | 116 |
| White | 672 | 66.0 | ± 11.7 | 66.0 | -2.0 | 94.0 | 430 | 1,102 |
| Other | 3 | 68.0 | ± 3.5 | 70.0 | 64.0 | 70.0 | 6 | 9 |
Race/Ethnicity vs AM Pulse 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 833 | 59.0 | ± 29.2 | 68.0 | -2.0 | 108.0 | 683 | 1,516 |
| Native American | 10 | 65.2 | ± 25.1 | 72.0 | -2.0 | 92.0 | 18 | 28 |
| Asian | 47 | 57.0 | ± 27.4 | 66.0 | -2.0 | 80.0 | 42 | 89 |
| Black | 73 | 59.7 | ± 30.1 | 68.0 | -2.0 | 96.0 | 99 | 172 |
| Hispanic | 57 | 68.6 | ± 23.7 | 76.0 | -2.0 | 96.0 | 59 | 116 |
| White | 643 | 58.0 | ± 29.7 | 68.0 | -2.0 | 108.0 | 459 | 1,102 |
| Other | 3 | 69.3 | ± 8.3 | 72.0 | 60.0 | 76.0 | 6 | 9 |
Race/Ethnicity vs AM Pulse 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 851 | 65.9 | ± 12.6 | 66.0 | -2.0 | 100.0 | 665 | 1,516 |
| Native American | 13 | 71.0 | ± 6.9 | 72.0 | 60.0 | 82.0 | 15 | 28 |
| Asian | 50 | 65.9 | ± 6.9 | 64.0 | 53.0 | 90.0 | 39 | 89 |
| Black | 75 | 67.9 | ± 11.8 | 66.0 | -1.0 | 94.0 | 97 | 172 |
| Hispanic | 61 | 67.1 | ± 12.5 | 66.0 | -1.0 | 90.0 | 55 | 116 |
| White | 649 | 65.5 | ± 13.1 | 66.0 | -2.0 | 100.0 | 453 | 1,102 |
| Other | 3 | 70.7 | ± 9.9 | 66.0 | 64.0 | 82.0 | 6 | 9 |